Session Datesort descending
EMPEROR-PRESERVED Trial – Empagliflozin for HFpEF 03/07/2022 - 12:00pm to 1:00pm
PATH-BP Trial & Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension 04/06/2022 - 6:00pm to 7:00pm
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial 06/06/2022 - 12:00pm to 1:00pm
Treating Hypertension in Pregnancy – Results from the CHAP Trial 08/01/2022 - 6:00pm to 7:00pm
ESC Congress 2022 Updates: Key Clinical Trials 10/03/2022 - 12:00pm to 1:00pm
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial 12/12/2022 - 12:00pm to 1:00pm